205 related articles for article (PubMed ID: 17367410)
21. Lysine acetylation regulates Bruton's tyrosine kinase in B cell activation.
Liu Z; Mai A; Sun J
J Immunol; 2010 Jan; 184(1):244-54. PubMed ID: 19949111
[TBL] [Abstract][Full Text] [Related]
22. Redistribution of Bruton's tyrosine kinase by activation of phosphatidylinositol 3-kinase and Rho-family GTPases.
Nore BF; Vargas L; Mohamed AJ; Brandén LJ; Bäckesjö CM; Islam TC; Mattsson PT; Hultenby K; Christensson B; Smith CI
Eur J Immunol; 2000 Jan; 30(1):145-54. PubMed ID: 10602036
[TBL] [Abstract][Full Text] [Related]
23. Amplification of IL-21 signalling pathway through Bruton's tyrosine kinase in human B cell activation.
Wang SP; Iwata S; Nakayamada S; Niiro H; Jabbarzadeh-Tabrizi S; Kondo M; Kubo S; Yoshikawa M; Tanaka Y
Rheumatology (Oxford); 2015 Aug; 54(8):1488-97. PubMed ID: 25724205
[TBL] [Abstract][Full Text] [Related]
24. Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells.
Mahajan S; Vassilev A; Sun N; Ozer Z; Mao C; Uckun FM
J Biol Chem; 2001 Aug; 276(33):31216-28. PubMed ID: 11413148
[TBL] [Abstract][Full Text] [Related]
25. Role of Bruton's tyrosine kinase in macrophage apoptosis.
Khare A; Viswanathan B; Gund R; Jain N; Ravindran B; George A; Rath S; Bal V
Apoptosis; 2011 Apr; 16(4):334-46. PubMed ID: 21193961
[TBL] [Abstract][Full Text] [Related]
26. Bruton's tyrosine kinase as a molecular target in treatment of leukemias and lymphomas as well as inflammatory disorders and autoimmunity.
Uckun FM; Qazi S
Expert Opin Ther Pat; 2010 Nov; 20(11):1457-70. PubMed ID: 20831363
[TBL] [Abstract][Full Text] [Related]
27. STAP-2 is phosphorylated at tyrosine-250 by Brk and modulates Brk-mediated STAT3 activation.
Ikeda O; Miyasaka Y; Sekine Y; Mizushima A; Muromoto R; Nanbo A; Yoshimura A; Matsuda T
Biochem Biophys Res Commun; 2009 Jun; 384(1):71-5. PubMed ID: 19393627
[TBL] [Abstract][Full Text] [Related]
28. Vanadate-induced inhibition of BCR-triggered apoptosis is coupled with tyrosine phosphorylation and induction of G2M growth arrest in Ramos-BL B cells.
Hristov KK; Knox KA; Mitev VI
Immunol Invest; 2007; 36(3):293-306. PubMed ID: 17558712
[TBL] [Abstract][Full Text] [Related]
29. Bruton's tyrosine kinase (BTK) as a dual-function regulator of apoptosis.
Uckun FM
Biochem Pharmacol; 1998 Sep; 56(6):683-91. PubMed ID: 9751072
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo chemosensitizing activity of LFM-A13, a dual-function inhibitor of Bruton's tyrosine kinase and polo-like kinases, against human leukemic B-cell precursors.
Uckun F; Dibirdik I; Sarkissian A; Qazi S
Arzneimittelforschung; 2011; 61(4):252-9. PubMed ID: 21650085
[TBL] [Abstract][Full Text] [Related]
31. Bruton tyrosine kinase (BTK) and its role in B-cell malignancy.
Buggy JJ; Elias L
Int Rev Immunol; 2012 Apr; 31(2):119-32. PubMed ID: 22449073
[TBL] [Abstract][Full Text] [Related]
32. Establishing a chemical genetic link between Bruton tyrosine kinase activity in malignant B cells and cell functions involved in the micro-environmental dialogue.
Göckeritz E; Vondey V; Guastafierro A; Pizevska M; Hassenrück F; Neumann L; Hallek M; Krause G
Br J Haematol; 2017 Sep; 178(6):949-953. PubMed ID: 28573668
[TBL] [Abstract][Full Text] [Related]
33. A FLIPR-based assay to assess potency and selectivity of inhibitors of the TEC family kinases Btk and Itk.
Douhan J; Miyashiro JS; Zhou X; Cole DC; Wu PW; Collins M; Dunussi-Joannopoulos K
Assay Drug Dev Technol; 2007 Dec; 5(6):751-8. PubMed ID: 18181691
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3.
Incrocci R; Barse L; Stone A; Vagvala S; Montesano M; Subramaniam V; Swanson-Mungerson M
Virology; 2017 Jan; 500():96-102. PubMed ID: 27792904
[TBL] [Abstract][Full Text] [Related]
35. Bruton's tyrosine kinase (BTK) is a binding partner for hypoxia induced mitogenic factor (HIMF/FIZZ1) and mediates myeloid cell chemotaxis.
Su Q; Zhou Y; Johns RA
FASEB J; 2007 May; 21(7):1376-82. PubMed ID: 17264170
[TBL] [Abstract][Full Text] [Related]
36. SYK and LYN mediate B-cell receptor-independent calcium-induced apoptosis in DT-40 lymphoma B-cells.
Zhu DM; Tibbles HE; Vassilev AO; Uckun FM
Leuk Lymphoma; 2002 Nov; 43(11):2165-70. PubMed ID: 12533043
[TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of sulfonamide-substituted diphenylpyrimidines (SFA-DPPYs) as potent Bruton's tyrosine kinase (BTK) inhibitors with improved activity toward B-cell lymphoblastic leukemia.
Liu H; Qu M; Xu L; Han X; Wang C; Shu X; Yao J; Liu K; Peng J; Li Y; Ma X
Eur J Med Chem; 2017 Jul; 135():60-69. PubMed ID: 28432946
[TBL] [Abstract][Full Text] [Related]
38. A Novel Aziridine-based Bruton's Tyrosine Kinase Inhibitor Induces Apoptosis Through Down-regulation of p65/RelA Phosphorylation on Serine 536 and ERK1/2 in Mantle Cell Lymphoma.
Romanchikova N; Strods A; Strazdina J; Strumfs B; Trapencieris P
Anticancer Res; 2016 Nov; 36(11):6133-6140. PubMed ID: 27793942
[TBL] [Abstract][Full Text] [Related]
39. Activation of STAT3 induced by cerebral ischemia in rat hippocampus and its possible mechanisms.
Li HC; Zhang GY
Sheng Li Xue Bao; 2003 Jun; 55(3):311-6. PubMed ID: 12817299
[TBL] [Abstract][Full Text] [Related]
40. Regulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3.
Kawakami Y; Inagaki N; Salek-Ardakani S; Kitaura J; Tanaka H; Nagao K; Kawakami Y; Xiao W; Nagai H; Croft M; Kawakami T
Proc Natl Acad Sci U S A; 2006 Jan; 103(1):153-8. PubMed ID: 16371463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
